Article info

Download PDFPDF
PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer

Authors

  1. Correspondence to Dr Jessica Bate, Department of Paediatric Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, SO16 9YD, UK; jessica.bate1{at}nhs.net
View Full Text

Citation

Bate J, Baker S, Breuer J, et al
PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer

Publication history

  • Received October 2, 2017
  • Revised February 16, 2018
  • Accepted April 17, 2018
  • First published May 5, 2018.
Online issue publication 
December 13, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.